← FDA Drug Approvals (Drugs@FDA)

CARNEXIV

NDA · New Drug Application · Sponsor: LUNDBECK PHARMS LLC · Approved 2016-10-07

Drug application

FDA Application #

NDA206030

Application type

New Drug Application

Brand name

CARNEXIV

Generic name

Carbamazepine

Active ingredients

CARBAMAZEPINE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

LUNDBECK PHARMS LLC

First approval

2016-10-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown